Previous 10 | Next 10 |
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: shutterstock.com/Anastasia Zagoruyko HeartBeam (NASDAQ: BEAT ) stock is seeing gains on Thursday as investors react to news of it expanding its product portfolio pipeline . That expansion has the comp...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Bukhta Yurii / Shutterstock.com Statera Biopharma (NASDAQ: STAB ) stock is rising higher on Thursday as the company holds a meeting with The Nasdaq Stock Market’s Nasdaq Hearings Panel. The me...
Statera Biopharma ( NASDAQ: STAB ) provided an update on its request for a hearing before the Nasdaq Hearings Panel caused by delayed filing of its form 10-Q for the June quarter with the U.S. SEC in a timely manner. STAB had previously said that it had got ...
FORT COLLINS, CO / ACCESSWIRE / September 9, 2022 / Statera Biopharma, Inc. (NASDAQ:STAB) (the "Company" or "Statera Biopharma"), a biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, today announced - as disclosed via the C...
NEW YORK, Aug. 26, 2022 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market ® (Nasdaq: NDAQ) announced that trading resumed in Statera Biopharma, Inc. (Nasdaq: STAB) today, August 26, 2022 at 7:10 a.m. Eastern Time. Trading in the company’s stock was halted on August 25, 2022 at 11:...
Statera Biopharma ( NASDAQ: STAB ) on Thursday said it had got an expected additional notice of non-compliance from Nasdaq due to the company's failure to file its form 10-Q for the June quarter with the U.S. SEC in a timely manner. STAB had previously said that it had got...
FORT COLLINS, CO / ACCESSWIRE / August 25, 2022 / Statera Biopharma, Inc. (NASDAQ:STAB) (the "Company" or "Statera Biopharma"), a biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, today announced that, as expected, the Com...
NEW YORK, Aug. 25, 2022 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market ® (Nasdaq: NDAQ) announced that trading was halted today in Statera Biopharma, Inc. (Nasdaq: STAB) at 11:01:52 A.M. Eastern Time for "additional information requested" from the company at a last sale price of $0.21...
FORT COLLINS, Colo., June 14, 2022 (GLOBE NEWSWIRE) -- Statera Biopharma, Inc. (NASDAQ: STAB) (the “Company” or “Statera Biopharma”), a biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, today...
Statera Biopharma (NASDAQ:STAB) said on Monday it had received a letter from the Nasdaq on May 18 stating that it had failed to file its quarterly report on form 10-Q for the first quarter and therefore had not complied with Nasdaq listing rule. "Statera is searching to identify a new indepen...
News, Short Squeeze, Breakout and More Instantly...
Statera Biopharma Inc. Company Name:
STAB Stock Symbol:
NASDAQ Market:
Statera Biopharma Inc. Website:
Williams Industrial Services Group Inc. (WLMSQ) is expected to report $-0.15 for Q3 2023 Cellcom Israel Limited (CELJF) is expected to report for quarter end 2023-09-30 Central Japan Railway Co ADR (CJPRY) is expected to report for Q2 2024 CW Petroleum Corp (CWPE) is expected to repor...
Strategic Environmental & Energy Resources Inc (SENR) is expected to report for Q1 2024 Biocept Inc. (BIOCQ) is expected to report for Q1 2024 Kalera Public Limited Company (KALRQ) is expected to report for quarter end 2023-09-30 Lanvin Group Holdings Limited (LANV) is expected to...
Murata Manufacturing Co. Ltd. ADR (MRAAY) is expected to report $0.27 for Q2 2024 Quotient Limited (QTNTQ) is expected to report for quarter end 2023-09-30 Evaxion Biotech A/S (EVAX) is expected to report for Q3 2023 American Virtual Cloud Technologies Inc. (AVCTQ) is expected to repo...